Day 4
XVIII International AIDS Conference

published on July 21, 2010

Key Events:
Use of Antiretrovirals for Prevention: PrEP, PEP and ART
Dr. Julio Montaner presents IAS/ANRS Young Investigator Award

DAY 4 | Wednesday, July 21

Use of Antiretrovirals for Prevention: PrEP, PEP and ART

Despite years of prevention efforts, HIV incidence has been inadequately controlled and the HIV/AIDS epidemic remains a global public health crisis. The global response has not been sufficient and the current economic crisis threatens recent gains. Given the gravity of the situation, it is not surprising that the question of how best to use antiretroviral treatment (ART) for prevention has emerged. There is increasing evidence that ART has an effect on both horizontal and vertical HIV transmission, and that it reduces mortality in TB/HIV co-infection. Some experts believe that the implementation of voluntary universal testing programmes, with immediate initiation of ART for individuals who test positive, could significantly reduce HIV incidence. However, expert evaluation and further research are required to assess this novel approach, evaluate its appropriateness and feasibility, and define the requirements for public health decision-making on how to best use ART for prevention.

The benefits of antiretroviral drugs can also be extended further into prevention for HIV-negative individuals through antiretroviral pre- and post-exposure prophylaxis. A number of clinical trials to study the effectiveness of pre- exposure prophylaxis are ongoing and results will most likely be available before data from planned field trials on the use of universal test and treat (for HIV-positive individuals). This session will explore the potential synergies of the use of antiretrovirals for HIV-positive and HIV-negative individuals.

Presentations in This Session:

Julio Montaner (Canada)
Helen Rees (South Africa)
Teguest Guerma (Kenya)
Godefridus J. P. van Griensven (Netherlands)
Geoffrey Garnett (United Kingdom)
Myron Cohen (United States)

Video courtesy of the Kaiser Family Foundation

Dr. Julio Montaner presents IAS/ANRS Young Investigator Award

Dr. Julio Montaner and IAS/ANRS Young Investigator Award recipients BC-CfE director Dr. Julio Montaner presented the IAS/ANRS Young Investigator Award to seven up-and-coming researchers prior to Wednesday's plenary session.

The US$2,000 IAS/ANRS Young Investigator Award is jointly funded by the IAS and the Agence Nationale de Recherche sur le SIDA (ANRS) to support young researchers who demonstrate innovation, originality, rationale and quality in the field of HIV and AIDS research. To be eligible, the presenting author of an abstract accepted for presentation must be under 35 years of age. One prize is awarded in each of the six conference tracks.

The tracks and HIV Reservoirs Workshop winners are:

Track A: Basic Science
Winner: Stephanie Planque, USA
Abstract Title: Prototype covalent HIV vaccine for inducing antibodies that neutralize genetically divergent virus strains

Track B: Clinical Sciences
Winner: Gabriel Chamie, USA
Abstract Title: TB microbiologic and clinical outcomes in a randomized trial of immediate vs CD4 initiated antiretroviral therapy (ART) in HIV+ adults with high CD4 cell counts

Track C: Epidemiology and Prevention Sciences
Winner: Joseph Larmarange, Mali
Abstract Title: Mapping HIV prevalence in Africa for a better understanding of epidemics: example from Burkina Faso using 2003 demographic and health survey data

Track D: Social and Behavioural Sciences
Winner: Michaela Leslie-Rule, Tanzania
Abstract Title: The language of love: Tanzanian women define intimacy, sexuality and violence in the 21st century

Track E: Economics, Operations Research, Care and Health Systems
Winner: Gesine Meyer-Rath, United States
Abstract Title: Total cost and potential cost savings of the national antiretroviral treatment (ART) programme in South Africa 2010 to 2017

Track F: Policy, Law, Human Rights and Political Science
Winner: Khalil Elouardighi, France
Abstract Title: Biogeneric development : when trade secret law clashes with research ethics

HIV Reservoirs Workshop
Winner: Patricia Monteiro, Canada
Abstract Title: Peripheral blood CCR4+ CCR6+ and CXCR3+ CCR6+ CD4+ T cells are highly permissive to HIV- 1 infection

BC Centre for Excellence in HIV/AIDS

Search form

Day 4
XVIII International AIDS Conference

Search form

Day 4 XVIII International AIDS Conference

Search form

Day 4
XVIII International AIDS Conference